Minimizing bias in randomized trials: the importance of blinding
JAMA
.
2010 Aug 18;304(7):793-4.
doi: 10.1001/jama.2010.1161.
Authors
Bruce M Psaty
1
,
Ross L Prentice
Affiliation
1
Cardiovascular Health Research Unit, Department of Medicine, University of Washington and Center for Health Studies, Group Health, Seattle, WA 98101, USA. psaty@u.washington.edu
PMID:
20716744
DOI:
10.1001/jama.2010.1161
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
Bias*
Double-Blind Method*
Endpoint Determination
Randomized Controlled Trials as Topic / statistics & numerical data*
Single-Blind Method*
Treatment Outcome
Grants and funding
CA53996/CA/NCI NIH HHS/United States
HL078888/HL/NHLBI NIH HHS/United States
HL080295/HL/NHLBI NIH HHS/United States
HL085251/HL/NHLBI NIH HHS/United States
HL087652/HL/NHLBI NIH HHS/United States